PMID 27592340
FDA released 81 PSGs (17 new, 64 revised) that provide recommendations to support the development of safe, effective, and high-quality generic medicines
Compounding pharmacies : Some offer custom combos, but FDA warns against this due to contamination risks, inconsistent dosing, and lack of safety data (no large trials)
We commonly use BPC-157 as part of our treatment for the following conditions: Chronic gastrointestinal (GI) issues, including colitis, Crohns disease, irritable bowel disease (IBD), gastritis, ulcers, and esophagitis
As polymeric, inorganic, and lipid-based nanoparticles are designed using more accurate methods, they can be optimized for more personalized medication administration, ushering in the era of precision medicine (Fig